Biomarkers associated with future suicide risk enhance predictive performance in psychiatric inpatients - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Biomarkers Linked to Future Suicide Risk Improve Predictive Accuracy in Psychiatric Hospitalized Patients

  • By

  • Zheya Cai

  • Enzhao Zhu

  • Jianmeng Dai

  • Xu Zhang

  • Jiayi Wang

  • Xiuake Bahuojia

  • Ruyi Shui

  • Qiuyi Lu

  • Duoduo Bai

  • Shengbei Liu

  • Ruichen Tang

  • Xin Wang

  • Qianyi Yu

  • Han Yang

  • Guoquan Zhou

  • Siqi Liu

  • Zhihao Chen

  • Yuqin Weng

  • Xinyi Tang

  • Huan Wang

  • Huiqing Pan

  • Tongxing Ou

  • Yue Liu

  • Weiwei Xu

  • Kexin Chen

  • Xunuo Lu

  • Wenjing Wang

  • Xuqi Song

  • Zongyuan Wang

  • Feng Wang

  • Dong Wang

  • Kang Ju

  • Liangliang Chen

  • Yichao Yin

  • Chunbo Li

  • Yanping Zhang

  • Pu Ai

  • Tianyu Ji

  • Weizhong Shi

  • Jiaojiao Hou

  • Fazhan Chen

  • Hui Li

  • Zisheng Ai

  • March 27, 2026

Share

Clinical Scorecard: Biomarkers Linked to Future Suicide Risk Improve Predictive Accuracy in Psychiatric Hospitalized Patients

At a Glance

CategoryDetail
ConditionSuicide Risk in Psychiatric Inpatients
Key MechanismsAssociation of biomarkers with suicide risk and predictive potential using machine learning.
Target PopulationPsychiatric inpatients aged 18-65 with bipolar disorder, depressive disorder, or schizophrenia.
Care SettingMulticentre psychiatric hospitals in China.

Key Highlights

  • Study analyzed data from 2785 first-admission psychiatric inpatients.
  • Nine biomarkers associated with elevated suicide risk identified.
  • Machine learning model achieved an AUC of 0.808 for predictive accuracy.
  • Biomarkers significantly enhanced predictive accuracy when combined with clinical data.
  • Study supports objective assessments in suicide risk evaluation.

Guideline-Based Recommendations

Diagnosis

  • Utilize the Nurses’ Global Assessment of Suicide Risk for structured evaluation.

Management

  • Incorporate biomarkers into suicide risk models for improved objectivity.

Monitoring & Follow-up

  • Monitor changes in identified biomarkers over time to assess risk escalation.

Risks

  • Subjective clinical judgement may lead to variability in suicide risk assessments.

Patient & Prescribing Data

Psychiatric inpatients with depressive disorder, schizophrenia, or bipolar disorder.

Biomarkers can guide early interventions and support clinical decision-making.

Clinical Best Practices

  • Implement machine learning models to enhance suicide risk prediction.
  • Use propensity score matching to minimize confounding in risk assessments.
  • Regularly evaluate and integrate objective biomarkers in clinical practice.

Related Resources & Content

    Original Source(s)

    Related Content